Versigent (NYSE:VGNT) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Versigent (NYSE:VGNT) had its price objective hoisted by research analysts at Wells Fargo & Company from $42.00 to $48.00 in a research report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price would suggest a potential upside of 11.69% from the stock’s current price.

Several other research analysts have also commented on VGNT. Wall Street Zen upgraded shares of Versigent to a “hold” rating in a research note on Saturday, April 18th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $38.00 price objective on shares of Versigent in a report on Thursday, May 7th. UBS Group increased their target price on shares of Versigent from $49.00 to $58.00 and gave the stock a “buy” rating in a research report on Friday, June 5th. BNP Paribas Exane initiated coverage on Versigent in a report on Tuesday, April 28th. They set an “outperform” rating and a $41.00 target price on the stock. Finally, TD Cowen upped their price target on Versigent from $47.00 to $49.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Versigent presently has an average rating of “Moderate Buy” and a consensus price target of $47.33.

Versigent Stock Performance

Shares of NYSE VGNT traded up $0.76 during trading hours on Thursday, hitting $42.98. The stock had a trading volume of 186,952 shares, compared to its average volume of 2,298,309. The company’s 50-day moving average price is $41.81. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88.

Versigent (NYSE:VGNT) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $999.00 earnings per share for the quarter.